RecruitingISRCTN10628149
This study is recruiting in Israel. It focuses on ADHD.
In IsraelADHDOtherFrom 6 Years to 12 Years
- Countries
- Israel
- Sponsor
- Etz-HaChayim Clinic (Israel)
- Condition
- ADHD
RecruitingISRCTN85247318
This study is recruiting in Australia. It is testing brain stimulation for ADHD.
In AustraliaADHDOtherFrom 18 Years to 35 Years
- Countries
- Australia
- Sponsor
- Neurode Labs Pty. Ltd.
- Condition
- ADHD
RecruitingISRCTN16827947
This study is recruiting in the United Kingdom. It is testing Concerta XL on reducing ADHD symptoms and behavioural problems for ADHD.
In United KingdomADHDOtherFrom 16 Years to 25 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- ADHD
RecruitingNCT07380412
This study is recruiting in the United States. It focuses on ADHD.
In Las VegasADHDBehavioralFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Outliers, Inc.
- Condition
- ADHD
RecruitingNCT07001475
This study is recruiting. It focuses on ADHD and currently lists participation information in Germany.
Multiple locations, including BerlinADHDDrugA study involving a medication or substance.From 18 Years to 45 Years
- Countries
- Germany
- Sponsor
- Boehringer Ingelheim
- Condition
- ADHD
RecruitingISRCTN60701389
This study is recruiting in the United Kingdom. It focuses on ADHD.
In United KingdomADHDOtherFrom 6 Years to 12 Years
- Countries
- United Kingdom
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Condition
- ADHD
RecruitingNCT06299189
This study is recruiting in Norway. It focuses on ADHD.
In BergenADHDBehavioralOver 18 Years
- Countries
- Norway
- Sponsor
- Haukeland University Hospital
- Condition
- ADHD
RecruitingNCT06248229
This study is recruiting. It focuses on ADHD and currently lists participation information in the United States.
In Rochester HillsADHDDrugFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Rochester Center for Behavioral Medicine
- Condition
- ADHD
RecruitingNCT07086313
This study is recruiting in Japan. It is testing EB-1020 for ADHD.
In SapporoADHDDrugFrom 6 Years to 17 Years
- Countries
- Japan
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Condition
- ADHD
RecruitingNCT07219810
This study is recruiting. It focuses on ADHD and currently lists participation information in the United States.
In East ProvidenceADHDBehavioralFrom 12 Years to 18 Years
- Countries
- United States
- Sponsor
- Bradley Hospital
- Condition
- ADHD
RecruitingNCT03425669
This study is recruiting. It focuses on ADHD and currently lists participation information in Sweden.
In LundADHDDeviceA study involving a tool, app, wearable, test, or medical device.From 9 Years to 18 Years
- Countries
- Sweden
- Sponsor
- Lund University
- Condition
- ADHD
RecruitingNCT06860763
This study is recruiting. It focuses on ADHD and currently lists participation information in China.
In BeijingADHDDrugFrom 6 Years to 12 Years
- Countries
- China
- Sponsor
- The Third Affiliated Hospital of Beijing University of Chinese Medicine
- Condition
- ADHD
